Sinopsis
Podcast by Dr. Cush
Episodios
-
RheumNow Podcast – I Wanna New Drug.V2 (9.24.2021)
24/09/2021 Duración: 23minNew to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Study of 435 #SLE pts seen during the pandemic. Comparing those seen F2F vs telemedicine, there was no significant difference in SLE disease activity (by SLEDAI-2K) or SLE flare rates or steroid prescribing between visit types https://bit.ly/39wWoQ6 Encouraging DBRPCT of Rituximab in #PMR: 116 screened, 49 enrolled, 47 completed: 23 on RTX vs 24 on PBO. Steroid-free remission at 21 wks seen with 11/23 (48%) RTX pts vs 5/24 (21%) on PBO (p=0·049). Infusion Rxns: 10 RTX vs 3 PBO); 1 SAE (PE) on RTX https://bit.ly/3lSI0rj Pregnancies exposed to ixekizumab (from Eli Lilly Global Safety Database) found 193 pts with psoriasis, PsA, or axSpA who were IXE exposed. Live births reported for 53.8 and 61.1% of known
-
RheumNow Podcast – Do More DMARDs Mean More Switching? (9.17.2021)
17/09/2021 Duración: 25minNew to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Metanalysis of JAK inhibition (tofacitinib & ruxolitinib) in alopecia areata - 12 studies, 346 Pts, Rx success (using SALT50 resp) was 66%, not influenced by age, sex, subtype. Alopecia recurrence seen w/in 3 mos of JAK D/C (in74%) https://t.co/CBSy4Kci80 Population study shows risk of H. Zoster in adults to be high among bDMARD and CTX, also increased w/ AZA and HCQ but not MTX SSZ or LEF users. Data from 254065, 1,826311 Pt-Yrs F/U, 6295 new DMARD users, 17024 incident HZ https://t.co/1TeOAWN9LB MMWR reports that during the COVID Delta variant era, Vaccination against COVID-19: - Reduces risk of COVID-19 infection 5X - Reduces risk of COVID-19 Hospitalization ⋗10X - Reduces risk of COVID-19 DEATH 1
-
RheumNow Podcast – High Science and Future Treatments (9.10.2021)
10/09/2021 Duración: 18minDr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com
-
Rheumatologist Views on new FDA JAK inhibitor Boxed Warnings
03/09/2021 Duración: 24minDr. Jack Cush is joined by Drs. Kathryn Dao (Dallas), Rachel Tate (Palm Beach), William Shergy (Huntsville) and Jeffrey Sparks (Boston)
-
RheumNow Podcast – JAK Inhibitor Warnings from the FDA (9.3.2021)
03/09/2021 Duración: 25minDr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com
-
Expert Panel Inital Views on FDA Warnings for JAK Inhibitors
02/09/2021 Duración: 28minDr. Jack Cush is joined by Drs. Roy Fleischmann (Dallas), Allan Gibofsky (NYC), and Artie Kavanaugh (San Diego)
-
RheumNow Podcast – COVID Marching Amidst the Madness (8.27.2021)
27/08/2021 Duración: 21minDr. Jack Cush reviews the news, journal reports and cautions regarding COVID-19
-
RheumNow Podcast – Driving in Pain (8.20.2021)
20/08/2021 Duración: 19minDr. Jack Cush reviews the news, journal articles and more from this past week on RheumNow.com
-
RheumNow Podcast – Booster Shots for COVID (8.13.2021)
13/08/2021 Duración: 18minDr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com
-
RheumNow Podcast – Saphnelo (Anifrolumab) Approved for Lupus (8.6.2021)
06/08/2021 Duración: 17minDr Jack Cush reviews the news, journal reports and FDA approvals from the past week on RheumNow.com
-
RheumNow Podcast – Psoriatic Arthritis Without Psoriasis (7.30.2021)
30/07/2021 Duración: 18minDr Jack Cush reviews rheumatology and COVID news from the past week on RheumNow.com
-
RheumNow Podcast – World Going to Pot (7.23.2021)
27/07/2021 Duración: 20minDr Jack Cush reviews the news and journal articles from this past week on RheumNow.com
-
RheumNow Podcast – What Not to Do (7.16.2021)
16/07/2021 Duración: 19minDr Jack Cush reviews the news and journal reports from the past week on RheumNow.com
-
RheumNow Podcast – As Good As I Ever Was (7.2.2021)
02/07/2021 Duración: 19minDr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
-
RheumNow Podcast – Modern Treatment of RA Pregnancy (6.25.2021)
25/06/2021 Duración: 17minDr. Jack Cush Reviews this weeks news and journal reports featured on RheumNow.com
-
RheumNow Podcast - Speak Up! (6.18.2021)
18/06/2021 Duración: 11minDr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!
-
RheumNow Podcast - Best of EULAR 2021 (6.11.21)
11/06/2021 Duración: 24minDr. Jack Cush reviews his highlight favorite abstracts and presentations from last weeks viirtual EULAR 2021 meeting
-
RheumNow Podcast - EULAR 2021 & EULAR-IQ
04/06/2021 Duración: 11minDr. Jack Cush reviews highlight presentations from Virtual EULAR 2021
-
EULAR 2021 - Day2d
04/06/2021 Duración: 23minWhat does Scleroderma with ScL70 Look Like_ with Dr. Janet Pope, EULAR 2021 Abatacept in RA ILD_ Dr. Richard Conway Combined Analysis of Peripheral Blood + Synovial Tissue in Early RA_ Dr. Aurelie Najm Comparative Effectiveness_ Registries or Real Life_ Dr. Jonathan Kay Gender, Racial Disparities in PsA Patients_ Dr. Rachel Tate How to Watch EULAR 2021 with Dr. Jack Cush
-
EULAR 2021 - Day2c
04/06/2021 Duración: 37minIberdomide_ A Novel Drug for Lupus_ Dr. Kathryn Dao IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus_ Drs. Yusof and Carter Impact of Pandemic on Rheumatology Training_ Drs. Dao and Young Impact of RA on Male Fertility_ New Data with Dr. Aurelie Najm, EULAR 2021 MUC5B and Lung Disease in RA_ Dr. Richard Conway New 2021 GRAPPA Treatment Guidelines for Adult PsO and PsA Patients with Dr. Rachel Tate, EULAR 2021 Predictors of PSA Development in Psoriasis Patients_ Drs. Studenic and Zabotti